Wang S X, Nakamura N, Mure M, Klinman J P, Sanders-Loehr J
Departments of Chemistry and Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.
J Biol Chem. 1997 Nov 14;272(46):28841-4. doi: 10.1074/jbc.272.46.28841.
Lysine tyrosylquinone (LTQ) recently has been identified as the active site cofactor in lysyl oxidase by isolation and characterization of a derivatized active site peptide. Reported in this study is the first characterization of the underivatized cofactor in native lysyl oxidase by resonance Raman (RR) spectrometry. The spectrum is characterized by a unique set of vibrational modes in the 1200 to 1700 cm-1 region. We show that the RR spectrum of lysyl oxidase closely matches that of a synthetic LTQ model compound, 4-n-butylamino-5-ethyl-1,2-benzoquinone, in aqueous solutions but differs significantly from those of other topa quinone-containing amine oxidases under similar conditions. Furthermore, we have observed the same 18O shift of the C=O stretch in both the lysyl oxidase enzyme and the LTQ cofactor model compound. The RR spectra of different model compounds and their D shifts give additional evidence for the protonation state of LTQ cofactor in the enzyme. The overall similarity of these spectra and their shifts shows that the lysyl oxidase cofactor and the model LTQ compound have the same structure and properties. These data provide strong and independent support for the new cofactor structure, unambiguously ruling out the possibility that the structure originally reported had been derived from a spurious side reaction during the derivatization of the protein and isolation of the active site peptide.
通过对衍生化活性位点肽段的分离和表征,赖氨酸酪氨酰醌(LTQ)最近被确定为赖氨酰氧化酶的活性位点辅因子。本研究首次通过共振拉曼(RR)光谱对天然赖氨酰氧化酶中未衍生化的辅因子进行了表征。该光谱的特征在于在1200至1700 cm-1区域有一组独特的振动模式。我们表明,赖氨酰氧化酶的RR光谱与合成的LTQ模型化合物4-正丁基氨基-5-乙基-1,2-苯醌在水溶液中的光谱紧密匹配,但在相似条件下与其他含topa醌的胺氧化酶的光谱有显著差异。此外,我们在赖氨酰氧化酶和LTQ辅因子模型化合物中都观察到了C=O伸缩振动的相同18O位移。不同模型化合物的RR光谱及其D位移为酶中LTQ辅因子的质子化状态提供了额外的证据。这些光谱及其位移的总体相似性表明,赖氨酰氧化酶辅因子和模型LTQ化合物具有相同的结构和性质。这些数据为新的辅因子结构提供了有力且独立的支持,明确排除了最初报道的结构源自蛋白质衍生化和活性位点肽段分离过程中虚假副反应的可能性。